---
title: "Translational Bridge"
description: "Bridging the gap between AI/ML innovations and practical research and clinical applications to accelerate biomedical discovery and patient care."
order: 3
cover: "../../assets/research-translational.jpg"
---

# Translational Bridge

We serve as a critical bridge connecting the power of AI and machine learning with the practical needs of researchers and clinicians. This translational focus ensures that cutting-edge computational methods don't remain isolated in the AI world but become accessible, usable tools that accelerate biomedical discovery and improve patient outcomes. We actively work to close the gap between what's possible with AI and what's practical in research labs and clinical settings.

## Bridging the Gap

### Understanding Both Worlds
- **AI/ML Expertise**: Deep understanding of machine learning methods, their capabilities and limitations
- **Biological Domain Knowledge**: Comprehensive grasp of genomics, disease biology, and clinical needs
- **Practical Constraints**: Awareness of real-world limitations in clinical and research settings

### Making AI Accessible
- **User-Friendly Interfaces**: Web-based tools requiring no programming expertise
- **Interpretable Results**: Clear explanations that bridge technical and clinical language
- **Actionable Outputs**: Results that directly inform research decisions and clinical care
- **Training & Education**: Workshops and documentation to empower users

### Two-Way Communication
- **Clinician Feedback**: Continuous input from end-users shapes tool development
- **Research Integration**: Embedding tools into existing laboratory workflows
- **Iterative Improvement**: Rapid cycles of development, testing, and refinement based on real-world use

## Key Research Areas

### AI-Powered Rare Disease Diagnosis

#### AI-MARRVEL (AIM)
Our flagship machine learning system, published in NEJM AI, helps clinicians prioritize potentially causative genetic variants for Mendelian disorders. Diagnosing rare genetic diseases is often a multi-year "diagnostic odyssey" - AI-MARRVEL significantly accelerates this process by:

- **Variant Prioritization**: Ranking genetic variants based on their likelihood of causing disease
- **Evidence Integration**: Combining diverse data sources including population genetics, functional predictions, model organism data, and clinical phenotypes
- **Clinical Phenotype Matching**: Leveraging HPO (Human Phenotype Ontology) terms to match patient symptoms with known disease profiles
- **Literature Mining**: Automatically extracting relevant information from millions of scientific publications

### Autism Research & Diagnosis

Supported by grants from the **NIH Autism Data Science Initiative** and the **Silicon Valley Community Foundation**, our autism research program focuses on:

#### Data-Driven Discovery
- **Large-Scale Data Analysis**: Mining autism genomic databases to identify risk genes and pathways
- **Molecular Subtyping**: Defining biologically meaningful autism subtypes based on molecular signatures
- **Biomarker Development**: Identifying molecular markers for early diagnosis and treatment response

#### Mechanistic Understanding
- **Gene Network Analysis**: Understanding how autism risk genes interact and contribute to disease
- **Cellular Pathways**: Identifying disrupted biological pathways that can be therapeutic targets
- **Brain Development**: Studying how genetic variants affect neurodevelopment

### Undiagnosed Disease Programs

We collaborate with clinical genetics programs to solve the most challenging diagnostic cases:

- **Whole Genome/Exome Analysis**: Comprehensive analysis of patient genetic data
- **Novel Gene Discovery**: Identifying previously unknown disease genes
- **Variant Interpretation**: Determining the pathogenicity of rare variants
- **Family Studies**: Analyzing inheritance patterns and segregation

### Neurological Disease Applications

#### Neurodegenerative Diseases
- **Cellular Heterogeneity**: Defining how different cell types are affected in neurodegeneration
- **Disease Progression**: Modeling molecular changes over disease course
- **Therapeutic Target Identification**: Finding druggable pathways and proteins

#### Neurodevelopmental Disorders
- **Gene Discovery**: Identifying new neurodevelopmental disease genes
- **Genotype-Phenotype Correlations**: Understanding how specific mutations lead to clinical features
- **Functional Validation**: Testing disease mechanisms in model systems

## Clinical Impact

### Diagnostic Rate Improvement
Our tools have helped increase diagnostic rates for rare diseases, ending diagnostic odysseys for numerous families and enabling precision medicine approaches.

### Clinical Decision Support
We provide clinicians with interpretable, evidence-based recommendations that integrate seamlessly into existing clinical workflows.

### Personalized Medicine
By understanding the molecular basis of each patient's condition, we enable tailored treatment approaches and inform prognosis.

## Translational Research Infrastructure

### Clinical Collaborations
- **Texas Children's Hospital**: Close collaboration with clinical genetics and neurology departments
- **Baylor College of Medicine**: Integration with genetic testing laboratories
- **Undiagnosed Diseases Network**: Participation in national collaborative efforts
- **International Partnerships**: Contributing to global rare disease initiatives

### Patient-Centered Approach
Our research is guided by the needs of patients and families affected by rare genetic disorders. We actively engage with patient advocacy groups and incorporate patient perspectives into our tool development.

### Regulatory & Clinical Validation
We work toward clinical-grade tools that meet regulatory standards and undergo rigorous validation in clinical settings.

## Real-World Implementation

### Web-Based Platforms
User-friendly interfaces that require no programming expertise, making advanced AI accessible to all clinicians.

### Secure Data Handling
HIPAA-compliant infrastructure ensuring patient privacy and data security.

### Continuous Improvement
Ongoing updates incorporating new scientific knowledge, clinical feedback, and improved machine learning models.

## Future Directions

- **Expanded Disease Coverage**: Extending our methods to broader categories of genetic disorders
- **Therapeutic Predictions**: Using AI to suggest potential treatments based on molecular mechanisms
- **Real-Time Clinical Integration**: Embedding our tools directly into electronic health records
- **Multi-Modal Data**: Incorporating imaging, clinical notes, and other data types for comprehensive diagnosis
